Clinical trials
Observational trials in Estonia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
115 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 8 |
| 2012 | 8 |
| 2013 | 6 |
| 2014 | 7 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 10 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 72 |
| Recruiting | 21 |
| Unknown status | 10 |
| Active, not recruiting | 6 |
| Terminated | 4 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Tartu | 20 |
| Abbott Medical Devices | 6 |
| Boehringer Ingelheim | 6 |
| Bayer | 5 |
| Tartu University Hospital | 5 |
| European Society of Anaesthesiology | 4 |
| Hoffmann-La Roche | 4 |
| North Estonia Medical Centre | 4 |
| AbbVie | 3 |
| GlaxoSmithKline | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 5 |
| COVID-19 | 4 |
| Coronary Artery Disease | 4 |
| Hemophilia A | 4 |
| Arthritis, Rheumatoid | 3 |
| Breast Neoplasms | 3 |
| Cardiovascular Diseases | 3 |
| Crohn Disease | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Heart Failure | 3 |
Trials
Showing 76 to 100 of 115. Each trial links to its page on Pharma Observatory.
15 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.